scispace - formally typeset
H

Hunter C. Champion

Researcher at Johns Hopkins University

Publications -  275
Citations -  23191

Hunter C. Champion is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Pulmonary hypertension & Adrenomedullin. The author has an hindex of 74, co-authored 275 publications receiving 21959 citations. Previous affiliations of Hunter C. Champion include Johns Hopkins University School of Medicine & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Positive inotropic and lusitropic effects of HNO/NO− in failing hearts: Independence from β-adrenergic signaling

TL;DR: HNO/NO− has positive inotropic and lusitropic action, which unlike NO/nitrates is independent and additive to β-adrenergic stimulation and stimulates CGRP release, which suggests potential of HNO/ NO− donors for the treatment of heart failure.
Journal ArticleDOI

Targeting Nrf2 with the triterpenoid CDDO-imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in mice.

TL;DR: Protection from CS-induced emphysema depended on NRF2, as Nrf2−/− mice failed to show significant reduction inAlveolar cell apoptosis and alveolar destruction after treatment with CDDO-Im, which suggests that targeting the Nrf1 pathway during the etiopathogenesis of emphySEma may represent an important approach for prophylaxis against COPD.
Journal ArticleDOI

L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial.

TL;DR: There was no significant change from baseline to 6 months in the vascular stiffness measurements or left ventricular ejection fraction in either of the 2 groups, including those 60 years or older and the entire study group.
Journal ArticleDOI

Clinical differences between idiopathic and scleroderma-related pulmonary hypertension

TL;DR: There are significant clinical and survival differences between IPAH and PAH-Scl, and the presence of left heart disease, although more common in PAH, was not predictive of the higher mortality in these patients.
Journal ArticleDOI

RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes-associated erectile dysfunction

TL;DR: Data imply that inhibition of RhoA/Rho-kinase improves eNOS protein content and activity thus restoring erectile function in diabetes, demonstrating a previously undescribed mechanism for the down-regulation of penile eNos in diabetes.